Free Trial

Pro-Dex Q4 2024 Earnings Report

Pro-Dex logo
$32.00 -1.33 (-3.99%)
As of 02/21/2025 04:00 PM Eastern

Pro-Dex EPS Results

Actual EPS
$0.46
Consensus EPS
$0.35
Beat/Miss
Beat by +$0.11
One Year Ago EPS
N/A

Pro-Dex Revenue Results

Actual Revenue
$15.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pro-Dex Announcement Details

Quarter
Q4 2024
Time
TAS

Conference Call Resources

Pro-Dex Earnings Headlines

Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.
Returns On Capital At Pro-Dex (NASDAQ:PDEX) Have Stalled
See More Pro-Dex Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pro-Dex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pro-Dex and other key companies, straight to your email.

About Pro-Dex

Pro-Dex (NASDAQ:PDEX) designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

View Pro-Dex Profile

More Earnings Resources from MarketBeat